ORGS (Orgenesis) Company Profit

Official company branding of orgenesis.com (ORGS)

Orgenesis Inc. minimizes risks through a decentralized gene therapy manufacturing network for global biotech clients. The company's financial results visualize this trend, where -0.03 represents the latest metric reading. The business scales by supplying software and equipment to clinics, and the development of the current product line by 2026 will significantly simplify the logistics of complex genetic drugs.

Company Net Income: Orgenesis Corporation (ORGS) for 07/04/2022 - 10/26/2024

Financial and market metric breakdowns for Orgenesis (ORGS)

- stock value and consensus price forecast:
Market Price Orgenesis Corporation|ORGS - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Orgenesis Corporation|ORGS - Total Company Value
- book capitalization information:
Net Asset Value per Share Orgenesis|ORGS - Company Book Value|Market Value to Book Value orgenesis.com|ORGS - Company Total Assets
- debt and liquidity details:
Debt to Capital Ratio Orgenesis Inc.|ORGS - Long-Term Debt to Capital|Current Liabilities to Capital Orgenesis Inc|ORGS - Company Debts|Debt to Book Value Ratio Orgenesis Corporation|ORGS - Company Long-Term Debts|Short-Term Debt Orgenesis|Interim Coverage Ratio orgenesis.com
- company profitability and valuation multiples indicators:
ORGS - Net Profit
Basic company analysis:Orgenesis Corporation
Original product of Orgenesis Inc.

The risk of capital stagnation when buying at the cycle peak necessitates an analysis of daily cash flows that shape the company's annual financial result. For Orgenesis Inc. (ORGS), this metric reflects the efficiency of implementing autonomous robotic cell processing centers, allowing investors to determine the business's actual ability to generate profit without inflating laboratory staff through fundamental support levels.

Direct competitors

Company Net Income Veeva Corp (VEEV)|DOCS (Doximity, Inc.) - Net Profit|Company Profit HQY (healthequity.com)|Company Net Income Waystar (WAY)|CRVL - Company Net Income|Company Net Income Privia Health Corp PRVA|Final Profit HURN|Certara, Inc. - Net Profit|Annual Net Income omnicell.com (OMCL)|GDRX: Net Profit|Company Net Income Schrodinger Inc (SDGR)|Company Net Income Phreesia Corp|Company Profit OMDA (Omada)|Net Profit EVH|HSTM - Company Net Income|Company Net Income Definitive Healthcare Corp. DH|Net Financial Result Consensus Cloud Solutions Inc (CCSI)|agilon health Inc - Net Profit|Net Financial Result Absci Bio ABSI|So-Young International (SY) - Company Net Income|NRC - Net Financial Result|Net Income SPOK|OPRX: Final Profit|Net Profit TBRG|Net Financial Result Simulations Plus Inc.|Company Net Income SOPHiA GENETICS SOPH|HCAT: Company Profit|CareCloud Corp - Net Profit|researchsolutions.com (RSSS) - Net Income|DLHC (dlhcorp.com) - Net Income|ONMD - Net Financial Result|Company Net Income Scienture Holdings Inc|Company Net Income healthcaretriangle.com HCTI|Company Net Income iSpecimen Inc. (ISPC)|BFRG (bullfrogai.com) - Final Profit|Net Profit WORX (SCWorx Corporation)|Annual Net Income MSP Recovery Corp|ICCT - Company Net Income|Net Financial Result trxadehealth.com MEDS|RCM: Net Profit|SHCR - Net Financial Result|Net Income STRM|SYRA (Syra Health, Corp.) - Profit After Payment of Taxes|Net Income AMEH (Apollo Medical Holdings)|MODN (modeln.com) - Final Profit|Company Net Income NextGen Healthcare, Inc. NXGN